Wayne Forrest[email protected]Clinical NewsTraining in FDG-PET/CT advances lung cancer outcomeAdditional training in FDG-PET/CT to monitor concurrent chemotherapy for patients with stage III non-small cell lung cancer can significantly extend both overall and progression-free survival, according to an international study published in the October issue of European Journal of Nuclear Medicine and Molecular Imaging.September 15, 2019Clinical NewsSwiss cast new light on prostate cancer analysisResearchers from Zurich have found gallium-68 prostate-specific membrane antigen offers better sensitivity, while multiparametric MRI provides better specificity, especially when determining tumor cell spread beyond the lymph node capsule or when prostate cancer extends into the seminal vesicles.September 15, 2019Clinical NewsNovel PET method advances in traumatic brain injuryA research team from the U.K. and Sweden has used dynamic flortaucipir-PET imaging to show that single moderate-to-severe traumatic brain injury can trigger signs of accumulation of neurodegenerative tau protein and lead to cognitive decline.September 12, 2019Molecular ImagingMerging PET and MRI assists in large-vessel vasculitisFrench investigators have combined contrast-enhanced anatomic assessments of MRI with the quantitative measurement of FDG uptake in PET to accurately characterize and differentiate between inflammation and fibrosis in the aortic walls and auxiliary branches of patients with large-vessel vasculitis.September 11, 2019Clinical NewsGa-68 PMSA PET/CT aids in prostate cancer recurrenceItalian researchers have created a gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) PET/CT-based model to accurately predict which prostate cancer patients are likely to show recurrence. Their study was published on 6 September in the European Journal of Nuclear Medicine and Molecular Imaging.September 11, 2019Clinical NewsMS patients show signs of gadolinium retention on MRISeeing is believing for Italian researchers who used MRI to visually confirm evidence of gadolinium retention in patients with multiple sclerosis (MS). Their study included patients who had undergone several MRI scans with a gadolinium-based contrast agent. The findings were published 4 September in Insights into Imaging.September 10, 2019Nuclear RadiologyAuntMinnieEurope.com Molecular Imaging InsiderJuly 21, 2019Clinical NewsPET/MRI develops growing role in cervical cancerPET/MRI can become an increasingly valuable modality for the early-stage diagnosis of cervical cancer, especially when the disease spreads to the parametrium, according to a study published on 17 July in the European Journal of Radiology.July 21, 2019Clinical NewsPET makes progress in determining Alzheimer's riskA Swedish-led group has developed a novel technique that uses florbetapir-PET scans for tracking beta-amyloid accumulation in adults to gauge the risk of progression to Alzheimer's disease. The investigators published their findings online on 17 July in JAMA Neurology.July 21, 2019Clinical NewsAustrians show MRI can be safe for implanted devicesLow-field MRI scans can be safe and of adequate diagnostic quality for patients with implanted cardiac rhythm management devices, according to an Austrian study published on 4 July in the European Journal of Radiology.July 15, 2019Previous PagePage 5 of 46Next PageTop StoriesArtificial IntelligenceAI improves MRI diagnosis of prostate cancerAI assistance can help diagnose clinically significant prostate cancer on MRI, a Dutch study has found.HomeHow can we minimize errors caused by human factors?CTNew advice issued on cardiac CT for prosthetic heart valvesCTUkraine hosts international cardiovascular conferenceSponsor ContentJoin us 26 June at 6 p.m. CET for a FREE webinar!
